Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria
The DOI matches its Crossref record.
Abstract
Blood glucose measurements are generally accepted components of a modern diabetes self-management. The value of self-monitoring of blood glucose (SMBG) is, however, discussed controversially and only a few studies addressed the efficacy of SMBG under real-life conditions so far. In order to investigate whether the frequency of SMBG is related to long-term metabolic control, data from the DPV-Wiss-database, a standardized,prospective, computer-based documentation of diabetes care and outcome, were analyzed for patients with type 1(n = 19,491) and type 2 (n = 5,009) diabetes from 191 centers in Germany and Austria. Local HbA1c reference ranges were mathematically adjusted to the DCCT reference. For each patient, data from the most recent year of diabetes care were used. On average,patients with type 1 diabetes performed 4.4 blood glucose measurements/day. Corrected for age, gender, diabetes duration,on intensified (>or=4 daily injections or CSII) therapy (HbA1c reduction of 0.32% for one additional SMBG/day) compared to patients on conventional (1-3 daily injections) therapy(HbA1c-reduction of 0.16% for one additional SMBG/day). In 2,021 patients with insulin-treated type 2 diabetes (2.7 measurements/day), more frequent SMBG was associated with better metabolic control (HbA1c-reduction of 0.16% for one additionalSMBG/day, p < 0.0001), while in 2,988 patients on OAD or diet alone (2.0 measurements/day), more frequent blood glucose measurements were associated with higher HbA1c-levels(HbA1c-increase of 0.14% for one additional SMBG/day,p < 0.0001). These data indicate that more frequent SMBG are associated with better metabolic control in both, patients with type 1 and insulin-treated type 2 diabetes. Since no benefit ofSMBG on metabolic control was found in patients with type 2 diabetes on OAD or diet alone, SMBG should primarily be recommended for those patients with suboptimal metabolic control whereas the benefit of SHBG in non-insulin-treated patients with adequate HbA1c-levels remains uncertain.insulin therapy and center difference, the SMBG frequency was associated with better metabolic control (HbA1c-reduction of0.26% for one additional SMBG/day, p < 0.0001). HbA1c-reduction with higher frequency of SMBG was more pronounced in patients Blood glucose measurements are generally accepted components of a modern diabetes self-management. The value of self-monitoring of blood glucose (SMBG) is, however, discussed controversially and only a few studies addressed the efficacy of SMBG under real-life conditions so far. In order to investigate whether the frequency of SMBG is related to long-term metabolic control, data from the DPV-Wiss-database, a standardized,prospective, computer-based documentation of diabetes care and outcome, were analyzed for patients with type 1(n = 19,491) and type 2 (n = 5,009) diabetes from 191 centers in Germany and Austria. Local HbA1c reference ranges were mathematically adjusted to the DCCT reference. For each patient, data from the most recent year of diabetes care were used. On average,patients with type 1 diabetes performed 4.4 blood glucose measurements/day. Corrected for age, gender, diabetes duration,insulin therapy and center difference, the SMBG frequency wasassociated with better metabolic control (HbA1c-reduction of 0.26% for one additional SMBG/day, p < 0.0001). HbA1c-reduction with higher frequency of SMBG was more pronounced in patients on intensified (>or= 4 daily injections or CSII) therapy (HbA1c reduction of 0.32% for one additional SMBG/day) compared to patients on conventional (1-3 daily injections) therapy(HbA1c-reduction of 0.16% for one additional SMBG/day). In 2,021 patients with insulin-treated type 2 diabetes (2.7 measurements/day), more frequent SMBG was associated with better metabolic control (HbA1c-reduction of 0.16% for one additionalSMBG/day, p < 0.0001), while in 2,988 patients on OAD or diet alone (2.0 measurements/day), more frequent blood glucose measurements were associated with higher HbA1c-levels(HbA1c-increase of 0.14% for one additional SMBG/day, p < 0.0001). These data indicate that more frequent SMBG are associated with better metabolic control in both, patients with type 1 and insulin-treated type 2 diabetes. Since no benefit of SMBG on metabolic control was found in patients with type 2 diabetes on OAD or diet alone, SMBG should primarily be recommended for those patients with suboptimal metabolic control whereas the benefit of SHBG in non-insulin-treated patients with adequate HbA1c-levels remains uncertain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Monitoring of blood glucose less frequently than three to four times per day in adults and adolescents has been associated with less effective control of glycemia as measured by HbA 1c (150)(151)(152).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [152]
In the citing paper
“In a study of individuals aged 1 to over 65 years and treated with insulin, HbA 1c showed greater improvement with BGM performed 4 or more times per day than with BGM performed less frequently (152).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [152]
Citations
Cites
Still being checked.
Cited by
Items 201–237 of 237
González, A. S., Fernández, N. Q., López, A. P., Garzón, R. D., Fernández, M., & Barberá-Comes, G. (2015) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2015.01.003
Ciclo vigília/sono em portadores de diabetes mellitus tipo 1.
Barone, M. T. U. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2011.tde-23012012-164619
Obaid, B. (2015) · UC Research Repository (University of Canterbury) · doi:10.26021/9520
Youth and Adolescents with Type 1 Diabetes in the Life for a Child Program in Rwanda, Africa
Marshall, S. L. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
Self-monitoring of blood glucose—problems with progress
Pirie, F. J. (2009) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/22201009.2009.10872196
Autosurveillance glycémique et insulinothérapie intensifiée dans le diabète de type 1
Hanaire, H. P. (2010) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(10)70139-5
González, A. S., Fernández, N. Q., López, A. P., Garzón, R. D., Fernández, M., & Barberá-Comes, G. (2015) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2015.01.010
López, J. M. G. (2014) · Journal of Diabetes Metabolic Disorders & Control · doi:10.15406/jdmdc.2014.01.00010
CICLO VIGÍLIA/SONO EM PORTADORES DE DIABETES MELLITUS TIPO 1
Barreto, M. (2011)
Otieno, C. F., Wandolo, G., Lotodo, T. C., & Sekadde-Kigondu, C. B. (2015)
Schuchardt, N. (2008) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-1590
Hva karakteriserer pasienter med type 1 diabetes og høy HbA1c
Ræder, B. W. (2010) · NORA - Norwegian Open Research Archives
Teló, G. H. (2016) · Americanae (AECID Library)
Robinson-Vincent, K. A. (2015) · TSpace (University of Toronto)
Do all patients with diabetes require monitoring of glycemia?
Pogorelova, A. S. (2018) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2018-6-137-141
Uduku, C. N., Reddy, M., & Oliver, N. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816714-4.00007-7
Momani, A. (2019) · Research Explorer (The University of Manchester)
Stachura, A., Łagowska-Batyra, A., Gierszon, P., & Smoleń, A. (2019) · Acta Balneologica · doi:10.36740/abal201904102
Does HbA1c Remain the Most Important Therapeutic Target in Outpatient Management of Diabetes?
Gonzales, K. M., & Smith, S. (2021) · Wiley eBooks · doi:10.1002/9781119603207.ch8
Umsatzveränderungen in einzelnen Indikationsgruppen
Höer, A., Klein, S., Dathe, K., & Zimmermann, A. (2013) · Springer eBooks · doi:10.1007/978-3-642-38795-1_3
Current literature in diabetes
John Wiley & Sons, L. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.740
Дмитриевич, З. В., & Mustafina, V. R. (2022) · Medical Herald of the South of Russia · doi:10.21886/2219-8075-2022-13-1-43-51
Mota, R. B., Lamback, E. B., Lozovey, N. R., Caarls, M. B., Arruda, M., & Neto, L. V. (2016) · Journal of Endocrinology and Metabolism · doi:10.14740/jem369w
ROLE OF POSTGRANDIAL GLYCEMIA AND SELF-CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Petunina, N. A., Trukhina, L. V., & Валерьевна, Г. Е. (2011) · PROBLEMS OF ENDOCRINE PATHOLOGY · doi:10.21856/j-pep.2011.2.14
Gérard-Legagneur, C. (2011) · Publications Et Travaux Academiques de Lorraine (Universite de Lorraine)
Carvalho, D. M., Duarte, R., Kao, K., & Brandner, L. (2022) · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo · doi:10.26497/ao220015
MESA 2: INNOVACIONES TECNOLÓGICAS EN EL TRATAMIENTO DE LA DIABETES MELLITUS TIPO 1
Morosini, M. L. R., PROIETTI, A. E., Ré, M., Schindler, A., Medek, G., Dios, A. D., Larreburo, S. V., Mengoni, K., González, L. S., Méndez, J., et al. (2023) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v49i3.634
Microstrip Sensors for Biomedical Engineering
Elsheakh, D. N., & Eldamak, A. R. (2024) · Springer eBooks · doi:10.1007/978-3-031-39824-7_18
Kansal, M., Singh, B. K., & Chaubey, A. (2024) · International Journal of Advanced Research · doi:10.21474/ijar01/19589
Impacto del inicio de la monitorización flash de glucosa en pacientes adultos con diabetes tipo 1
Sahagún, R. J. (2024) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/72390
Teló, G. H. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Investigations of hypoglycemic events and the role of GABA in type 1 diabetes
Hill, H. (2025) · Uppsala University Publications (Uppsala University)
Lee, H. (2026) · Journal of Korean Diabetes · doi:10.4093/jkd.2026.27.2.85
Huang, Y., Nagesh, N., Subramanian, A., Wang, L., Liu, Z., Sun, Y.-C., Hou, W., Azimi, I., Rahmani, A. M., & Stafford, R. S. (2026) · JMIR Formative Research · doi:10.2196/95679
Martinez, Y. V. (2013) · Research Explorer (The University of Manchester)
Metadata
- Authors
- Schütt, M., Kern, Krause, U., Busch, Dapp, A., Grziwotz, Mayer, I., Rosenbauer, Wagner, C., Zimmermann, Kerner, W., & Holl, R.
- Affiliations
- University of Lübeck (DE)
- Universität Ulm (DE)
- SLK-Kliniken Heilbronn (DE)
- Kreiskrankenhaus Gummersbach (DE)
- Deutsches Diabetes-Zentrum e.V. (DE)
- Institute for Diabetes Gerhardt Katsch (DE)
- Venue
- Experimental and Clinical Endocrinology & Diabetes
- Publisher
- Georg Thieme Verlag KG
- Published
- 2006-08-16
- Volume
- 114
- Issue
- 07
- Pages
- 384-388
- ISSN
- 0947-7349 (ISSN-L)
- 1439-3646
- OpenAlex
- W1981356692
- Semantic Scholar
- 0b8be1a894b7fd40002ab06ebec43b86e55db9f1
- Cited by
- 218
- References
- 0
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 8 · 2023: 7 · 2022: 8 · 2021: 3 · 2020: 8 · 2019: 12 · 2018: 20 · 2017: 15 · 2016: 10 · 2015: 19 · 2014: 14 · 2013: 10 · 2012: 13
- FWCI
- 8.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Experimental and Clinical Endocrinology & Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bundesministerium für Gesundheit
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- self-monitoring of blood glucose, HbA1c, glycemic control, type 1 diabetes, type 2 diabetes, intensive insulin therapy, insulin pump therapy, oral antidiabetic drugs, diabetes self-management, real-world data
- MeSH terms
- Austria, Blood Glucose, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Germany, Homeostasis, Humans, Patient Compliance, Self Care, Blood Glucose Self-Monitoring, Databases, Factual
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.